Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.495
+0.025 (0.56%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Exagen Employees
As of December 31, 2024, Exagen had 215 total employees, including 209 full-time and 6 part-time employees. The number of employees increased by 36 or 20.11% compared to the previous year.
Employees
215
Change (1Y)
36
Growth (1Y)
20.11%
Revenue / Employee
$258,795
Profits / Employee
-$70,302
Market Cap
80.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
XGN News
- 5 weeks ago - Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025 - GlobeNewsWire
- 2 months ago - Exagen Inc. to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results - GlobeNewsWire
- 4 months ago - Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD - GlobeNewsWire
- 5 months ago - Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform - GlobeNewsWire
- 5 months ago - Exagen, Inc. (XGN) Q3 2024 Earnings Call Transcript - Seeking Alpha